Literature DB >> 24938920

Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness?

A Stiegler1, R Schaletzky, G Walter, R Wüst, H Abele, R Goelz, G Farger, G Wiatr, A J Fallgatter, A Batra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24938920     DOI： 10.1007/s00213-014-3647-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.

Authors:  D Jeffrey Newport; Martha R Calamaras; C Lindsay DeVane; Jennifer Donovan; Aquila J Beach; Stephanie Winn; Bettina T Knight; Bryan B Gibson; Adele C Viguera; Michael J Owens; Charles B Nemeroff; Zachary N Stowe
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

2.  Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

Authors:  Kate McKenna; Gideon Koren; Maria Tetelbaum; Lynda Wilton; Saad Shakir; Orna Diav-Citrin; Andrea Levinson; Robert B Zipursky; Adrienne Einarson
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

3.  Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months.

Authors:  A Whitworth; C Stuppaeck; K Yazdi; K Kralovec; C Geretsegger; G Zernig; W Aichhorn
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 4.  Antipsychotics in pregnancy.

Authors:  K McCauley-Elsom; C Gurvich; S J Elsom; J Kulkarni
Journal:  J Psychiatr Ment Health Nurs       Date:  2010-03       Impact factor: 2.952

5.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

Review 6.  Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

7.  Olanzapine treatment during breast feeding: a case report.

Authors:  Ulrich C Lutz; Gerlinde Wiatr; Thorsten Orlikowsky; Hans-Jörg Gaertner; Mathias Bartels
Journal:  Ther Drug Monit       Date:  2008-06       Impact factor: 3.681

Review 8.  Clinical utilization of atypical antipsychotics in pregnancy and lactation.

Authors:  Salvatore Gentile
Journal:  Ann Pharmacother       Date:  2004-05-18       Impact factor: 3.154

9.  Olanzapine plasma concentration in a newborn.

Authors:  W Aichhorn; K Yazdi; K Kralovec; H Steiner; S Whitworth; C Stuppaeck
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

10.  Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.

Authors:  Sharon J Gardiner; Judith H Kristensen; Evan J Begg; L Peter Hackett; Debbie A Wilson; Kenneth F Ilett; Rolland Kohan; Jonathan Rampono
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112
  10 in total
  2 in total

Review 1.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

Review 2.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.

Authors:  Eline M P Poels; Lisanne Schrijver; Astrid M Kamperman; Manon H J Hillegers; Witte J G Hoogendijk; Steven A Kushner; Sabine J Roza
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-11       Impact factor: 4.785
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.